Bruker BRKR
NASDAQ BRKR
$61.23 +2.58 (+4.40%)
At close: Aug 20, 2026 · 12:12 PM UTC

Bruker (BRKR) Non-Current Deferred Tax Liability (2010 - 2025)

Bruker's (BRKR) quarterly Non-Current Deferred Tax Liability came in at $112.5 million in Q4 2025, down 5.06% YoY from $118.5 million in Q4 2024, and down 5.06% on a QoQ basis from $118.5 million in Q4 2024.

Bruker (BRKR) Non-Current Deferred Tax Liability (2010 - 2025) Analysis & Trends

Bruker (BRKR) has 16 years of Non-Current Deferred Tax Liability data on file, last reported at $112.5 million in Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 5.06% year-over-year to $112.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $112.5 million (down 5.06% YoY) and the FY2025 annual result came in at $112.5 million, down 5.06% from the prior year.
  • Non-Current Deferred Tax Liability declined to $112.5 million in Q4 2025, from $118.5 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $178.5 million in Q2 2024 to a low of $46.0 million in Q4 2021.
  • A 5-year average of $105.7 million and a median of $97.1 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability soared 75.04% — and 2025, when it slipped 5.06%.
  • Tracing BRKR's Non-Current Deferred Tax Liability over 5 years: stood at $46.0 million in 2021, then surged by 35.43% to $62.3 million in 2022, then grew by 8.67% to $67.7 million in 2023, then jumped by 75.04% to $118.5 million in 2024, then slipped by 5.06% to $112.5 million in 2025.
  • The last three Non-Current Deferred Tax Liability figures came in at $112.5 million (Q4 2025), $118.5 million (Q4 2024), and $178.4 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.51 Bn 194.91 Bn 7.27 Bn
2 Stryker 129.96 Bn 126.48 Bn 4.50 Bn
3 Medtronic 120.18 Bn 110.96 Bn 6.41 Bn
4 Boston Scientific 74.28 Bn 73.74 Bn 3.85 Bn
5 Edwards Lifesciences 52.75 Bn 48.50 Bn 1.35 Bn
6 Dexcom 34.67 Bn 32.73 Bn 830.00 Mn
7 GE HealthCare Technologies 34.23 Bn 32.12 Bn 2.18 Bn
8 Koninklijke Philips 26.46 Bn 23.14 Bn 4.55 Bn
9 Steris 23.30 Bn 22.82 Bn 684.20 Mn
10 Bruker 9.32 Bn 9.32 Bn 416.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 112.50 Mn
Dec 31, 2025 112.50 Mn
Dec 31, 2024 118.50 Mn
Dec 31, 2024 118.50 Mn
Sep 30, 2024 178.40 Mn
Sep 30, 2024 178.40 Mn
Jun 30, 2024 178.50 Mn
Jun 30, 2024 178.50 Mn
Mar 31, 2024 81.80 Mn
Mar 31, 2024 81.80 Mn
Dec 31, 2023 67.70 Mn
Dec 31, 2023 67.70 Mn
Dec 31, 2022 62.30 Mn
Dec 31, 2022 62.30 Mn
Dec 31, 2021 46.00 Mn
Dec 31, 2021 46.00 Mn
Dec 31, 2020 43.10 Mn
Dec 31, 2020 43.10 Mn
Dec 31, 2019 48.80 Mn
Dec 31, 2019 48.80 Mn